tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA

Compare Innate Pharma (IPHA) vs. Competitors

132 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.41
$127.83M
-1.23
-22.48%
2 Buy
0 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$4.11
$854.81M
-18.84
328.83%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Therapeutics
$0.25
$104.07M
-0.95
-65.28%
1 Buy
1 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$10.15
$186.72M
-3.95
100.20%
3 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$15.47
$762.02M
-0.19
24.07%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.41
-0.49
-25.79%
SLS
SELLAS Life Sciences Group
4.76
3.62
317.54%
SGMO
Sangamo Therapeutics
0.25
-0.50
-66.53%
GNFT
ELTX
Elicio Therapeutics
10.15
5.23
106.30%
VOR
Vor Biopharma
15.47
1.65
11.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts